by GOT | Feb 18, 2022 | News
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO Woburn, Mass. – February 18, 2022 – Azurity Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing innovative medicines that meet the specific needs of underserved...
by GOT | Feb 7, 2022 | News
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF FLEQSUVY™ (baclofen oral suspension) WOBURN, MA, February 7, 2022-Azurity Pharmaceuticals, Inc., a private specialty pharmaceutical company, focused on developing innovative products to meet the unique needs of...
by GOT | Sep 20, 2021 | News
Azurity Pharmaceuticals Completes Acquisition of Arbor Pharmaceuticals WOBURN, MA & ATLANTA, GA (September 20, 2021) – Azurity Pharmaceuticals, Inc. (“Azurity”) is pleased to announce the closing of its acquisition of Arbor Pharmaceuticals, Inc. (“Arbor”), as...
by GOT | Sep 7, 2021 | News
Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of One Lot of Firvanq® (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Due to a Mix-Up of the Diluent Included in the Kit Company Contact: Koral Couch 781-935-8141 x119 FOR...
by GOT | Sep 1, 2021 | Legacy Arbor Archives
Arbor Supports Updated Clinical Recommendations for Restless Legs Syndrome Arbor has long recognized the need for effective treatment options for Restless Legs Syndrome (RLS) and support for the patients who suffer from it. We are pleased to support The Updated...
Recent Comments